Rethinking Gleason 6 Prostate Cancer: Embracing PrNLMP for Precision and Progress.
作者信息
Kovac Evan, Weiss Robert E, Arap Wadih
机构信息
Rutgers Cancer Institute, Newark, NJ, USA.
Division of Urology, Department of Surgery, Rutgers New Jersey Medical School, Newark, NJ, USA.
出版信息
Curr Urol Rep. 2025 Jul 14;26(1):57. doi: 10.1007/s11934-025-01285-1.
Abstract
摘要
相似文献
1
Rethinking Gleason 6 Prostate Cancer: Embracing PrNLMP for Precision and Progress.重新审视Gleason 6级前列腺癌：采用PrNLMP实现精准与进步。
Curr Urol Rep. 2025 Jul 14;26(1):57. doi: 10.1007/s11934-025-01285-1.
2
Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review.中危前列腺癌（Gleason 评分 7，国际泌尿病理学会 Gleason 分组 2-3）患者结局的变异性及其对风险分层的影响：系统评价。
Eur Urol Focus. 2017 Oct;3(4-5):487-497. doi: 10.1016/j.euf.2016.10.010. Epub 2017 Mar 11.
3
MRI Radiomics and Automated Habitat Analysis Enhance Machine Learning Prediction of Bone Metastasis and High-Grade Gleason Scores in Prostate Cancer.MRI影像组学与自动栖息地分析增强了前列腺癌骨转移和高分级Gleason评分的机器学习预测能力。
Acad Radiol. 2025 Jun 23. doi: 10.1016/j.acra.2025.05.059.
4
Epstein criteria for insignificant prostate cancer.前列腺癌不显著的 Epstein 标准。
BJU Int. 2011 Aug;108(4):518-25. doi: 10.1111/j.1464-410X.2011.09979.x. Epub 2011 Feb 14.
5
Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.前列腺癌的Gleason分级系统是否应进行修改以纳入高级别三级成分？一项系统评价和荟萃分析。
Lancet Oncol. 2007 May;8(5):411-9. doi: 10.1016/S1470-2045(07)70136-5.
6
VISION: An Individual Patient Data Meta-analysis of Randomised Trials Comparing Magnetic Resonance Imaging Targeted Biopsy with Standard Transrectal Ultrasound Guided Biopsy in the Detection of Prostate Cancer.愿景：一项个体患者数据荟萃分析，该分析涉及比较磁共振成像靶向活检与标准经直肠超声引导活检在前列腺癌检测中的随机试验。
Eur Urol. 2025 May;87(5):512-523. doi: 10.1016/j.eururo.2024.08.022. Epub 2024 Sep 3.
7
The volume of Gleason grade group 1 prostate cancer at biopsy predicts unfavorable pathology but not upgrading after radical prostatectomy.活检时Gleason分级1组前列腺癌的体积可预测不良病理结果，但不能预测根治性前列腺切除术后的病理升级。
Int Urol Nephrol. 2025 Jul 2. doi: 10.1007/s11255-025-04641-9.
8
Application of the PRECISION Trial Biopsy Strategy to a Contemporary Magnetic Resonance Imaging-Targeted Biopsy Cohort-How Many Clinically Significant Prostate Cancers are Missed?PRECISION 试验活检策略在当代磁共振成像靶向活检队列中的应用-有多少临床显著前列腺癌被遗漏？
J Urol. 2021 Mar;205(3):740-747. doi: 10.1097/JU.0000000000001406. Epub 2020 Oct 7.
9
Yield of bone scintigraphy for the detection of metastatic disease in treatment-naive prostate cancer: a systematic review and meta-analysis.骨闪烁显像在初治前列腺癌转移灶检测中的应用：一项系统评价与荟萃分析
Clin Radiol. 2018 Feb;73(2):158-167. doi: 10.1016/j.crad.2017.08.004. Epub 2017 Sep 25.
10
Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.维生素 D 受体基因变异与诊断时的晚期前列腺癌相关：来自前列腺癌检测和治疗研究以及系统综述的发现。
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2874-81. doi: 10.1158/1055-9965.EPI-09-0544. Epub 2009 Oct 27.
本文引用的文献
1
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up.临床局限性前列腺癌：AUA/ASTRO 指南，第二部分：主动监测原则、手术原则和随访。
J Urol. 2022 Jul;208(1):19-25. doi: 10.1097/JU.0000000000002758. Epub 2022 May 10.
2
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.MRI 靶向或标准活检用于前列腺癌诊断。
N Engl J Med. 2018 May 10;378(19):1767-1777. doi: 10.1056/NEJMoa1801993. Epub 2018 Mar 18.
3
A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.一种当代前列腺癌分级系统：格里森评分的有效替代方案。
Eur Urol. 2016 Mar;69(3):428-35. doi: 10.1016/j.eururo.2015.06.046. Epub 2015 Jul 10.
4
A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.一种 17 基因检测方法，可在格里森分级异质性、肿瘤多灶性和活检取样不足的情况下预测前列腺癌的侵袭性。
Eur Urol. 2014 Sep;66(3):550-60. doi: 10.1016/j.eururo.2014.05.004. Epub 2014 May 16.
5
Gleason score 6 adenocarcinoma: should it be labeled as cancer?Gleason评分6级腺癌：是否应将其标记为癌症？
J Clin Oncol. 2012 Dec 10;30(35):4294-6. doi: 10.1200/JCO.2012.44.0586. Epub 2012 Oct 1.
6
The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy.CAPRA-S 评分：一种用于改善根治性前列腺切除术预后预测的简单工具。
Cancer. 2011 Nov 15;117(22):5039-46. doi: 10.1002/cncr.26169. Epub 2011 Jun 3.
Zotero 插件